Cytogenetic risk groups of patients with AML who received autologous SCT and allogeneic SCT
| Cytogenetic risk groups . | No. patients . | ||
|---|---|---|---|
| Auto-SCT . | Allo-SCT . | Total . | |
| t(8;21) | 61 | 194 | 255 |
| inv(16) | 17 | 66 | 83 |
| t(15;17)* | 65 | 113 | 178 |
| Intermediate | 140 | 749 | 889 |
| Unfavorable | 35 | 325 | 360 |
| Unknown | |||
| Unknown cytogenetic risk | 27 | 178 | 205 |
| No available cytogenetic data | 44 | 150 | 194 |
| Total | 389 | 1775 | 2164 |
| Cytogenetic risk groups . | No. patients . | ||
|---|---|---|---|
| Auto-SCT . | Allo-SCT . | Total . | |
| t(8;21) | 61 | 194 | 255 |
| inv(16) | 17 | 66 | 83 |
| t(15;17)* | 65 | 113 | 178 |
| Intermediate | 140 | 749 | 889 |
| Unfavorable | 35 | 325 | 360 |
| Unknown | |||
| Unknown cytogenetic risk | 27 | 178 | 205 |
| No available cytogenetic data | 44 | 150 | 194 |
| Total | 389 | 1775 | 2164 |
Auto-SCT indicates autologous stem cell transplantation; Allo-SCT, allogeneic stem cell transplantation.
Patients with t(15;17) were excluded from the analysis.